Skip to main content
OpenTrials
Completed

NCT Number: NCT01222598

A Study of Minirin Melt in Patients With Nocturia

This is a confirmation of safety profile for Minirin Melt in clinical practice.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–64 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Private Ambulance, Blansko, Czechia

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients suffering from Nocturia

Exclusion criteria

  • habitual or psychogenic polydipsia
  • known or suspected cardiac insufficiency and other conditions requiring treatment with diuretics
  • moderate and severe renal insufficiency
  • know hyponatremia
  • syndrome of inappropriate ADH secretion

Treatment and study plan

Primary outcomes

  1. Number of participants with adverse events

    Time frame: 12 months

Secondary outcomes

  1. Number of participants with nocturnal voiding

    Time frame: 12 months

  2. Number of participants with adverse events

    Time frame: 12 months

Sponsors and collaborators

Lead sponsor

Ferring Pharmaceuticals

Industry

Registry information

Official study title

Minirin Melt Tolerance With Nocturia in the Common Practice Conditions in Czech Republic

Important dates

Study start
2008
Primary completion
2010
Study completion
2011
First posted
Oct 18, 2010
Registry last updated
Oct 8, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.